[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"bedsore\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:bedsore":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":31,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100607845","phase-4-zinc-oxide-vs-mebo-100607845",false,"NCT07193849","Zinc Oxide VS MEBO","Impact of Using Zinc Oxide Versus Moist Exposed Wound Ointment (MEBO) in Treatment of Second Stage Pressure Ulcer: A Randomized Control Clinical Trial","Inclusion Criteria:\n\n* Willing to participate.\n* KAMC cases in medical ward, neuroscience ward, and intensive care unit.\n* Newly cases diagnosed with second stage pressure ulcer according to the European pressure ulcer advisory panel\u002Fnational pressure ulcer advisory panel (NPUAP) guidelines.\n\nExclusion Criteria:\n\n* Not consenting to participate\n* Patients with suspected hypersensitivity reactions to any of the topical formulation's ingredients.\n* Either a category III or IV pressure ulcer.\n* Evidence of deep tissue injury (exudative drainage, purple or maroon localized area of discolored intact skin or blood-filled blister due to pressure damage).\n* Signs of wound infection (pus draining from the ulcer, a foul-smelling odour, tenderness, heat and increased redness in the surrounding skin and fever).\n* Patients who undertaking other therapies that could affect healing, such as corticosteroids, radiation therapy, or chemotherapy for cancer.\n* Heavy smoking (more than 20 cigarettes a day).\n* Concomitant chronic disease (e.g., diabetes mellitus or frank vascular disease such as Buerger's disease).\n* Patients who unable to continue the study because of death, discharge, or change in the care setting.","ALL","18 Years",{"count":19,"type":20},76,"ESTIMATED","INTERVENTIONAL",[23],"PHASE4","randomize control trial to evaluate the efficacy of using zinc oxide versus moist exposed wound ointment in treatment of second stage pressure ulcer.",[26,27,28,29,30],"Pressure Injury","Pressure Injury Stage 2","Bedsore","Pressure Ulcers Stage II","Pressure Ulcer, Buttock",[32,33,34,35],"pressure injury","pressure ulcer","MEBO","Zinc oixid","RECRUITING","2025-09-22",{"date":39,"type":40},"2025-09-26","ACTUAL",{"date":42,"type":40},"2023-12-31",{"date":44,"type":20},"2025-12-31",{"name":46,"class":47},"King Abdullah Medical City","OTHER_GOV",2]